- White spots around colorectal tumors are cancer-related findings and may aid endoscopic diagnosis: a prospective study in Japan
-
Korekawa K, Shimoyama Y, Fujishima F, Nagai H, Naito T, Moroi R, Shiga H, Kakuta Y, Kinouchi Y, Masamune A
- KMID: 2559215
- Clin Endosc.
- 2024 Sep;57(5):637-646.
- doi: 10.5946/ce.2024.027
Background/Aims: During endoscopy, white spots (WS) are sometimes observed around benign or malignant colorectal tumors; however, few reports have investigated WS, and their significance remains unknown. Therefore, we investigated the... -
- CITED
-
- Close
- SHARE
-
- Close
- Live-attenuated vaccination in patients with inflammatory bowel disease while continuing or after elective switch to vedolizumab
-
Shiga H, Nagai H, Shimoyama Y, Naito T, Moroi R, Kakuta Y, Kinouchi Y, Masamune A
- KMID: 2558197
- Intest Res.
- 2024 Jul;22(3):378-386.
- doi: 10.5217/ir.2023.00203
Background/Aims: Vedolizumab (VDZ) is a gut-selective agent with a favorable safety profile. We aimed to assess the feasibility of elective switch from other advanced therapies to VDZ and subsequent live-attenuated... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term prognosis of Japanese patients with biologic-naïve Crohn’s disease treated with anti-tumor necrosis factor-α antibodies
-
Moroi R, Endo K, Yamamoto K, Naito T, Onodera M, Kuroha M, Kanazawa Y, Kimura T, Kakuta Y, Masamune A, Kinouchi Y, Shimosegawa T
- KMID: 2438448
- Intest Res.
- 2019 Jan;17(1):94-106.
- doi: 10.5217/ir.2018.00048
BACKGROUND/AIMS: Few reports have described the long-term treatment outcomes of the anti-tumor necrosis factor-α antibody for Japanese Crohn’s disease (CD) patients. The aim of this study was to evaluate them... -
- CITED
-
- Close
- SHARE
-
- Close
